Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced the successful conclusion of its 2024 Annual General Meeting (AGM) held on June 3, 2025. All resolutions proposed at the meeting were approved by shareholders, marking a positive outcome for the company. The AGM was attended by a significant number of shareholders, with over half of the total issued shares being represented. This successful meeting underscores the company’s strong governance and shareholder engagement, potentially enhancing its position in the pharmaceutical industry.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$25.40 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company primarily focuses on the production and distribution of pharmaceutical products, serving both domestic and international markets.
Average Trading Volume: 1,388,448
Technical Sentiment Signal: Sell
Current Market Cap: HK$45.22B
See more data about 0874 stock on TipRanks’ Stock Analysis page.